B E A U T Y U N I T Y

比利時醫學美容先驅 - Auriga International

發佈日期: 2015-11-26 人氣: 6114

比利時世界級的醫學美容


AURIGA INTERNATIONAL 是一所專注醫學美容、發展醫生配方護膚產品超過十年之研發生產機構,AURIGA自設獨立實驗室,其專業研究團隊之研究人員均為專業醫生、藥劑師及博士人才。AURIGA為了更進一步推動科學研究,成立一個由十多名皮膚科和整形外科醫生組成的醫療委員會專責監察研究及提供意見,產品在歐美亞洲及本港多個地區已被皮膚專科醫生廣泛採用,AURIGA 自1997年開始推出一系列極具活性功效之銀杏、複合維生素及Peptide 等產品,結合獨特的微脂囊包裹技術,同時取得多項專利及國際大獎,是世界級的醫學美容產品。

今天,AURIGA INTERNATIONAL 跨越幾個對皮膚治療的標誌性專長和範圍,包括色素沉著,抗老化,整型手術後護理,黑眼圈色素改善,更年期症狀,疣治療及皮膚防禦機制和功能障礙等領域。

而實驗室擁有14個不同的產品線,包括該品牌的旗艦產品維生素C,維生素K氧化物和透明質酸;所有Auriga產品的成分都經由醫學研究團隊精心挑選,同時亦研究及尋找新奇和最尖端的科學發現,AURIGA INTERNATIONAL 的使命就是創新和滿足特定皮膚之需求,開發最前端的皮膚醫學美容產品。正是這種持續的承諾,以不斷的創新和尋求解決方案,使得該品牌在全球的59個國家及地區馳名。為了向您提供最高質量的皮膚醫學美容產品,所有經AURIGA 嚴格挑選的活性成分都由皮膚科醫生和大學測試成效,所有生產的產品亦經醫療產品委員會進行嚴格的管理。另外,為配合市場的需求,產品都經由醫生推薦並分發給藥劑師和醫學美容中心銷售,並不斷聆聽您的需求。


產品列表http://www.beautyunity.com/ally/store.php?id=1&action=good&tagid=14


AURIGA INTERNATIONAL CEO Mr. Alfred MARCHAL

Organic chemistry, PhD Brussels University ULB.
Graduate in Industrial Chemistry: Degree in chemistry engineering ESEA
Specialized in organic chemistry synthesis

- CEO at AURIGA International SA
- President of AURIGA France
- President of AURIGA Création
- CEO of AURIGA Hong Kong
- MCA Master in Management


 

里程碑

  • 1997


In 1997, Auriga was created thanks to the ingenious ideas of Alfred Marchal (CEO and PhD in chemistry).


  • 1998


1998, a team of researchers was mobilised and inaugurated the first Auriga research site.  From the start “Creativity and Rigour” were the key values of this team!We were at the dawn of a promising scientific adventure, supported by the launch of the first Auriga product: EXOVA®, tablets neutralising bad breath.


  • 1999


One year later, Auriga launched anti-ageing product FLAVO-C® serum based on active vitamin C. Flavo-C® serum has been the flagship product of the Auriga range since, thanks to the proven efficacy of its active ingredients.SI-NAILS® varnish was then developed to improve the growth and resistance of fragile and damaged nails.


  • 2000


While in 2000 the first Patents were filed, the products took their place within the Spanish, French and Luxembourg markets and Auriga became “Auriga International”


  • 2001


To best meet the needs of the French market, in 2001 Auriga created its French subsidiary: Auriga France.During this same year, a treatment was launched for dark circles under the eyes: CERNOR® cream based on vitamin K oxide, followed by AUREVEN® gel which deals with the problem of heavy legs by offering them lightness, comfort and freshness.


  • 2003


To reduce redness, bruising and contusions, in 2003 Auriga developed AURIDERM® XO cream, the star ingredients of which were vitamin K oxide, vitamin C and vitamin E.In the same year, CHIROXY® cream was launched.  This cream offers better oxygenation to the skin and fast repair of epidermal tissues.


  • 2004


To combat skin slackening of the face and body, in 2004 Auriga created FLAVONEX® cream, containing genistein.Still in 2004, Auriga decided to expand its anti-ageing range by devising Flavo-C® cream, ideal complement to FLAVO-C® serum. 


  • 2007


In 2007, aware of the negative impact of UV rays on the skin, Auriga developed a product to limit the pigmentation process. MELACLEAR® serum prevents and acts against pigment stains (melasma, lentigo, etc.)


  • 2008


In 2008, Auriga won the Grand Prix à l’Exportation awarded by the AWEX.   In the same year, Auriga expanded considerably with its entry into the Taiwanese, Chinese and Turkish markets, testimony to its smooth expansion internationally.


  • 2009


Wishing to meet a well-targeted dermatological need, in 2009 Auriga expanded into the development of a medical device: VERRUTOP®, intended for the treatment of warts.Auriga also persevered in its quest against skin ageing by creating a serum based on hyaluronic acid to fill in fine lines and wrinkles: AURIGENE® micro-emulsion P.It was also during this year 2009 that Auriga entered the world of influential companies on a worldwide scale as it was floated on the stock market. 


  • 2010


While in 2000 the first Patents were filed, the products took their place within the Spanish, French and Luxembourg markets and Auriga became “Auriga International”


  • 2011


Auriga extended further in 2011 by penetrating the Indian dermato-cosmetics market.Still in its quest for perfection, Auriga designed CERNOR® kit, the only product on the market capable of acting on all causes of dark circles under the eyes, whether of pigment or vascular origin.And in the same year, it innovated completely in the highly specialised market of dermatoporosis with its new product DERMATROPHIX® cream, a special and unique product that restores skin that has become thin and fragile through age or through certain drug treatments.


  • 2012

In April of this year 2012 Auriga released its brand new product ECLA-CELL® cream, anti-cellulite cream that considerably reduces the orange peel effect and remodels the figure.Furthermore, VERRUTOP® broadened its indications: in addition to treating skin warts, it also proved effective on genital warts. 


Your Ad Here
>